Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort
S. Koirala, S. Borisov, E. Danila, A. Mariandyshev, B. Shrestha, N. Lukhele, M. Dalcolmo, S. R. Shakya, S. Miliauskas, L. Kuksa, S. Manga, A. Aleksa, J. T. Denholm, H. B. Khadka, A. Skrahina, S. Diktanas, M. Ferrarese, J. Bruchfeld, A. Koleva, A. PiubelloG. S. Koirala, Z. F. Udwadia, D. J. Palmero, M. Munoz-Torrico, R. GC, G. Gualano, V. I. Grecu, I. Motta, A. Papavasileiou, Y. Li, W. Hoefsloot, H. Kunst, J. Mazza-Stalder, M. C. Payen, O. W. Akkerman, E. Bernal, V. Manfrin, A. Matteelli, H. Mustafa Hamdan, M. Nieto Marcos, J. Cadiñanos Loidi, J. J. Cebrian Gallardo, R. Duarte, N. Escobar Salinas, R. Gomez Rosso, R. Laniado-Laborín, E. Martínez Robles, S. Quirós Fernandez, A. Rendon, A. Šmite, Giovanni B. Migliori
Research output: Contribution to journal › Article › peer-review
43Citations
(Scopus)
5Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort'. Together they form a unique fingerprint.